MedPath

A Pilot Drug Trial That Evaluates the Whitening Potential of Nicotine Gum

Phase 4
Completed
Conditions
Dental Pellicle
Interventions
Drug: 2 mg nicotine gum
Drug: 4 mg nicotine gum
Registration Number
NCT00174499
Lead Sponsor
McNeil AB
Brief Summary

The purpose of this research study is to evaluate the effects on existing tooth stain of nicotine gum. The study will enroll adults who have visible tooth staining.

Detailed Description

This was a 6-week, open-label, single-center study conducted in 78 subjects who were smokers with visible staining of teeth and who were motivated to quit smoking through use of Nicorette Freshmint gum.

The subjects were assigned, per label instructions, to either Nicorette Freshmint gum 2 mg or 4 mg based on the number of cigarettes smoked per day. Subjects who smoked at least 25 or more cigarettes per day were assigned to the 4 mg gum group; those who smoked less than 25 cigarettes per day were assigned to the 2 mg gum group.

A total of 3 study visits were planned: Screening/Baseline, Week 2 and Week 6. A telephone screening prior to Baseline and the Screening/Baseline visit was performed to confirm subject eligibility. At each visit an oral examination, including a stain index measurement used to rate tooth-staining (MacPherson Modification of the Lobene Stain Index), was conducted; and smoking status and motivation to quit smoking were assessed. The safety evaluation at each visit included an oral tissue assessment in addition to assessment for any adverse events.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria
  • daily smokers for at least one year
  • motivated to quit smoking
  • normal chewing ability
  • willing to refrain from a dental prophylaxis for the duration of the study
  • total extrinsic facial tooth stain score > or = to 28, according to the MacPherson Modification of the Lobene Stain Index
Read More
Exclusion Criteria
  • < 20 natural teeth
  • inadequate oral hygiene
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
12 mg nicotine gum2 mg nicotine gum
24 mg nicotine gum4 mg nicotine gum
Primary Outcome Measures
NameTimeMethod
The primary objective of this study was to assess, by using the MacPherson modification of the Lobene Stain Index, the amount of extrinsic tooth-stain reduction from Baseline while quitting smoking using Nicorette Freshmint gum6 Weeks
Secondary Outcome Measures
NameTimeMethod
To assess smoking status6 Weeks
To assess safety6 Weeks
To assess reduction in tooth-staining in relation to usage of gums6 Weeks
© Copyright 2025. All Rights Reserved by MedPath